Instituto Mexicano del Seguro Social

7 marketed · 2 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Instituto Mexicano del Seguro Social

What are Instituto Mexicano del Seguro Social's marketed drugs?

Top marketed products include collagen-povidone solution, Doravirine + tenofovir DF + lamivudine, Intravenous Lidocaine infusion + Standard Anesthesia, Ondansetron Intraperitoneal Lavage, Perioperative magnesium sulfate, Saline Intraperitoneal Lavage.

What is Instituto Mexicano del Seguro Social's pipeline?

Instituto Mexicano del Seguro Social has 2 drugs in Phase 3, 1 in Phase 2, 1 in Phase 1. Late-stage candidates include Homologated placebo., intravenous salin water.

Related